LONA
LONA
NASDAQ · Pharmaceuticals

Leonabio Inc

$7.67
-0.01 (-0.13%)
As of Aug 8, 2:22 AM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +424.4% upside
Low Target $30.63
Average Target $40.22
High Target $46.08
Current Price $7.67
Current
$7.67
Target
$40.22
$30.63 $40.22 avg $46.08
Scenario Analysis
Bear Case
$30.63
299.3%
Low target
Base Case
$40.22
+424.4%
Avg target
Bull Case
$46.08
+500.8%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$14.21
-46.0% from high
52-Week Low
$3.53
+117.3% from low
Target vs 52W High
$40.22
+183.0% vs high
Next Earnings Report
Aug 17, 2026
8d
until earnings
EPS Est: $-1.29
Earnings in 8 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%